Dados do Trabalho

Título

HYPHEMA AFTER COMBINED TREATMENT WITH DIODE TRANSSCLERAL CYCLOPHOTOCOAGULATION (TCP) AND TRANSSCLERAL SUBCYCLOPHOTOTHERAPY (TSCP): A CASE REPORT

Resumo

Purpose: To present a case about a complication after TCP and TSCP combined treatment
in a refractory glaucoma patient.
Methods: An 80-year-old male patient with a diagnosis of refractory glaucoma who
underwent a combined TSCP (360°, 2W and 31.3% duty cycle for 90 seconds) and TCP
(180°, 2W for 2 seconds) with Vitra 810 Quantel Medical Equipment.
Results:
An 80-year-old male patient with medical history of schizophrenia treated with clozapine and
risperidone, exudative maculopathy in both eyes (OU) treated with vascular endothelial
growth factors, glaucoma treated with maximal medical therapy and trabeculectomy OU
and epiretinal membrane in the left eye (OS). Visual acuity was 8/10 in the right eye (OD)
and 2/10 OS. Intraocular pressure (IOP) was 19mmHg OD and 36 mmHg OS. A combined
TCP and TSCP technique was performed in the left eye. The following day, slit lamp
examination revealed in treated eye corneal folds, tyndall ++ and IOP dropped to 6 mmHg.
Patient was prescribed moxifloxacin + dexamethasone every 6 hours and difluprednate
every 8 hours. A week after the procedure, he presented inferior hyphema with an IOP of
9mmHg. It was decided to increase the frequency difluprednate and after two weeks slit
lamp examination showed no corneal folds, reabsorption of the hyphema and IOP of 9
mmHg.
Conclusion:
Diode cyclophotocoagulation is considered to be effective in reducing IOP in refractory
glaucoma patients. It has shown to be a safer technique with a lower complication rate
compared to other cyclodestructive procedures such as cryotherapy. Most common
complications are inflammation of the anterior chamber, hyphema, hypotonia and loss of
corneal transparency. These tend to be infrequent and quickly resolved with medical
treatment.

Referências Bibliográficas

Sanchez FG, Lerner F, Sampaolesi J, Noecker R, Becerra N, Iribarren G,
Grippo TM. Efficacy and Safety of Micropulse® Transscleral Cyclophotocoagulation in
Glaucoma. Arch Soc Esp Oftalmol (Engl Ed). 2018 Dec;93(12):573-579.
-Contreras I, Noval S, González Martín-Moro J, Rebolleda G, Muñoz-Negrete FJ. Picos
hipertensivos tras ciclofotocoagulación transescleral de contacto con láser diodo [IOP spikes
following contact transscleral diode laser cyclophotocoagulation]. Arch Soc Esp Oftalmol.
2004 Mar;79(3):105-9.
-Dhanireddy S, Yin HY, Dosakayala N, Kurochkin P, Gupta N, Cheng AMS, Fechtner R,
Alpert S. Severe Inflammation and Hyphema After Micropulse Diode Transscleral
Cyclophotocoagulation. J Glaucoma. 2020 Jun;29(6